Product NDC: | 45802-626 |
Proprietary Name: | Cetirizine Hydrochloride |
Non Proprietary Name: | Cetirizine hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; Cetirizine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-626 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078398 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080724 |
Package NDC: | 45802-626-26 |
Package Description: | 1 BOTTLE in 1 CARTON (45802-626-26) > 120 mL in 1 BOTTLE |
NDC Code | 45802-626-26 |
Proprietary Name | Cetirizine Hydrochloride |
Package Description | 1 BOTTLE in 1 CARTON (45802-626-26) > 120 mL in 1 BOTTLE |
Product NDC | 45802-626 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cetirizine hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20080724 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |